Internal Medicine Department, Gemelli Hospital, Catholic University of Sacred Heart, Largo A. Gemelli 8, 00168, Rome, Italy.
Intern Emerg Med. 2010 Oct;5 Suppl 1:S53-6. doi: 10.1007/s11739-010-0450-1.
Intestinal epithelium, mucosal immune system, and bacterial flora represent a morpho-functional system on dynamic balance responsible for the intestinal metabolic and trophic functions, and the regulation of mucosal and systemic host's immunity. Obesity is a pathological condition affecting a growing number of people especially in the Western countries resulting from the failure of the organism's energetic balance based on the perfect equality of income, waste, and storage. Recent evidences explain the mechanisms for the microbial regulation of the host's metabolism both in health and disease. In particular, animal studies have explained how quali-/quantitative changes in microflora composition are able to affect the absorption of the nutrients and the energy distribution. Antibiotics, prebiotics, probiotics, and symbiotics are the instruments utilized in the current clinical practice to modulate the intestinal bacterial flora in man both in health and pathologic conditions with promising preliminary results on prevention and therapy of obesity and related metabolic diseases.
肠上皮、黏膜免疫系统和细菌菌群代表了一个动态平衡的形态功能系统,负责肠道的代谢和营养功能,以及黏膜和全身宿主免疫的调节。肥胖是一种影响越来越多人的病理状况,特别是在西方国家,这是由于机体的能量平衡基于收入、废物和储存的完美平等而失败。最近的证据解释了微生物调节宿主代谢的机制,无论是在健康还是疾病状态下。特别是,动物研究解释了微生物菌群组成的质量/数量变化如何能够影响营养物质的吸收和能量分布。抗生素、益生元、益生菌和合生菌是目前临床上用于调节人类肠道细菌菌群的工具,在预防和治疗肥胖和相关代谢性疾病方面取得了有希望的初步结果。